Australia's 4DMedical jumps on funding for lung scanner
** Shares of 4DMedical Ltd 4DX.AX jump as much as 8.8% to
A$0.745 - set to mark best day since July 4, if gains hold
** Medical technology firm says it won A$1.1 mln
($739,860.00) funding via the Clinical Translation and
Commercialisation Medtech programme, a federal government scheme
** Funding will help co expand its XV lung scanner
capability beyond ventilation into perfusion
($1 = 1.4868 Australian dollars)
(Reporting by Poonam Behura in Bengaluru)
((Poonam.Behura@thomsonreuters.com;))
Recent news on 4DMedical
See all newsBrief: 4Dmedical Receives TGA Approval For CTVQ In Australia
Brief: 4Dmedical Launches Clear Clinical Evidence Program
Brief: 4Dmedical Creates EU Platform Via Contextflow Acquisition
Australia's 4DMedical rises on establishing European platform via acquisition
Brief: 4Dmedical Says CT:VQ Enters US Outpatient Market Via Simonmed's 170-Site Network